Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 1
1985 1
1986 2
2019 2
2020 3
2021 3
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501).
Watanabe S, Sakai K, Matsumoto N, Koshio J, Ishida A, Abe T, Ishikawa D, Tanaka T, Aoki A, Kajiwara T, Koyama K, Miura S, Goto Y, Sekiya T, Suzuki R, Kushiro K, Fujisaki T, Yanagimura N, Ohtsubo A, Shoji S, Nozaki K, Saida Y, Yoshizawa H, Nishio K, Kikuchi T. Watanabe S, et al. Among authors: yanagimura n. Cancers (Basel). 2022 Dec 29;15(1):204. doi: 10.3390/cancers15010204. Cancers (Basel). 2022. PMID: 36612200 Free PMC article.
Mediastinal Malignant Melanoma Markedly Shrinking in Response to Nivolumab.
Sakaguchi H, Tanimoto A, Sato S, Yanagimura N, Suzuki C, Takumi Y, Nishiyama A, Yamashita K, Takeuchi S, Ohtsubo K, Yano S. Sakaguchi H, et al. Among authors: yanagimura n. Intern Med. 2022 Jan 1;61(1):75-79. doi: 10.2169/internalmedicine.7452-21. Epub 2021 Jun 26. Intern Med. 2022. PMID: 34176837 Free PMC article.
Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients.
Kushiro K, Watanabe S, Goto Y, Fujisaki T, Yanagimura N, Ohtsubo A, Shoji S, Nozaki K, Tanaka T, Saida Y, Sato Y, Ota T, Koshio J, Hayashi Y, Miyabayashi T, Matsumoto N, Ichikawa K, Koyama K, Kikuchi T. Kushiro K, et al. Among authors: yanagimura n. Transl Lung Cancer Res. 2022 Sep;11(9):1858-1865. doi: 10.21037/tlcr-22-225. Transl Lung Cancer Res. 2022. PMID: 36248339 Free PMC article.
Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan.
Sato S, Tanimoto A, Yanagimura N, Suzuki C, Takumi Y, Nishiyama A, Yamashita K, Takeuchi S, Ohtsubo K, Makino T, Yoshida Y, Hirono Y, Hayashi R, Koizumi T, Nakazawa Y, Ito KI, Motoo Y, Uramoto H, Nakada M, Nishino Y, Yano S. Sato S, et al. Among authors: yanagimura n. Int J Clin Oncol. 2021 Jun;26(6):1009-1014. doi: 10.1007/s10147-021-01890-3. Epub 2021 Mar 1. Int J Clin Oncol. 2021. PMID: 33646436
Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like Mass.
Ohtsubo K, Yamashita K, Yanagimura N, Suzuki C, Tanimoto A, Nishiyama A, Takeuchi S, Iwaki N, Kawano M, Izumozaki A, Inoue D, Gabata T, Ikeda H, Watanabe M, Yano S. Ohtsubo K, et al. Among authors: yanagimura n. Intern Med. 2021 Feb 1;60(3):409-415. doi: 10.2169/internalmedicine.5429-20. Epub 2020 Aug 29. Intern Med. 2021. PMID: 32863365 Free PMC article.
Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinoma.
Nishiyama A, Sakaguchi H, Yanagimura N, Suzuki C, Otani S, Tanimoto A, Yamashita K, Takeuchi S, Ohtsubo K, Ikeda H, Yano S. Nishiyama A, et al. Among authors: yanagimura n. Oxf Med Case Reports. 2020 Dec 28;2020(12):omaa116. doi: 10.1093/omcr/omaa116. eCollection 2020 Dec. Oxf Med Case Reports. 2020. PMID: 33391772 Free PMC article.
17 results